APA
MDGL icon

American Portfolios Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

American Portfolios Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4.55K Sell
70
-21
-23% -$1.46K ﹤0.01% 2853
2022
Q2 		$6.51K Hold
91
– – ﹤0.01% 2736
2022
Q1 		$8.93K Hold
91
– – ﹤0.01% 2735
2021
Q4 		$7.71K Buy
91
+21
+30% +$1.73K ﹤0.01% 2730
2021
Q3 		$5.58K Hold
70
– – ﹤0.01% 2807
2021
Q2 		$6.82K Hold
70
– – ﹤0.01% 2683
2021
Q1 		$8.19K Buy
+70
New +$8.16K ﹤0.01% 2475

Other funds holding MDGL

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Portfolios Advisors's MDGL Position: Q3 2022 in Review

American Portfolios Advisors reduced its Madrigal Pharmaceuticals (MDGL) stake by 23% in Q3 2022, selling an estimated $1.46K and leaving 70 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2853.

American Portfolios Advisors first reported a position in MDGL in Q1 2021 and has held it in 7 quarters since. The position peaked at $8.93K in Q1 2022. 135 funds tracked by Wall St. Rank hold MDGL as of Q3 2022.

  • American Portfolios Advisors held 70 shares of Madrigal Pharmaceuticals worth $4.55K as of Q3 2022.
  • American Portfolios Advisors sold 21 Madrigal Pharmaceuticals shares in Q3 2022, an estimated $1.46K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2853 holding.
  • American Portfolios Advisors first reported a position in Madrigal Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
  • American Portfolios Advisors's Madrigal Pharmaceuticals position peaked at $8.93K in Q1 2022.
  • 135 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.